A novel ICK peptide from the Loxosceles intermedia (brown spider) venom gland: Cloning, heterologous expression and immunological cross-reactivity approaches

详细信息    查看全文

• 作者：Fern ; o Hitomi Matsubara ; Luiza Helena Gremski ; Gabriel Otto Meissner ; Eduardo Soares Constantino Lopes ; Waldemiro Gremski ; Andrea Senff-Ribeiro ; Olga Meiri Chaim ; Silvio Sanches Veiga
• 关键词：Loxosceles intermedia ; Spider venom ; ICK peptide ; Knottin
• 刊名：Toxicon
• 出版年：2013
• 出版时间：1 September, 2013
• 年：2013
• 卷：71
• 期：Complete
• 页码：147-158
• 全文大小：1558 K

文摘

The venom of a Loxosceles spider is composed of a complex mixture of biologically active components, consisting predominantly of low molecular mass molecules (3-45?kDa). Transcriptome analysis of the Loxosceles intermedia venom gland revealed ESTs with similarity to the previously described LiTx peptides. Sequences similar to the LiTx3 isoform were the most abundant, representing approximately 13.9 % of all ESTs and 32 % of the toxin-encoding messengers. These peptides are grouped in the ICK (Inhibitor Cystine Knot) family, which contains single chain molecules with low molecular mass (3-10?kDa). Due to their high number of cysteine residues, ICK peptides form intramolecular disulfide bridges. The aims of this study were to clone and express a novel ICK peptide isoform, as well as produce specific hyperimmune serum for immunoassays. The corresponding cDNA was amplified by PCR using specific primers containing restriction sites for the XhoI and BamHI enzymes; this PCR product was then ligated in the pET-14b vector and transformed into E. coli AD494 (DE3) cells. The peptide was expressed by IPTG induction for 4?h at 30?¡ãC and purified by affinity chromatography with Ni-NTA resin. Hyperimmune serum to the recombinant peptide was produced in rabbits and was able to specifically recognize both the purified recombinant peptide and the native form present in the venom. Furthermore, the recombinant peptide was recognized by antisera raised against L. intermedia, L. gaucho and L. laeta whole venoms. The recombinant peptide obtained will enable future studies to characterize its biological activity, as well as investigations regarding possible biotechnological applications.